QUOTE AND NEWS
Benzinga  Jun 3  Comment 
Trius Therapeutics (Nasdaq: TSRX), a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious infections, announced today Matthew Onaitis has been appointed to the newly created...
Benzinga  Mar 6  Comment 
Pernix Therapeutics Holdings (NASDAQ: PTX) today announced the completion of its acquisition of Somaxon Pharmaceuticals, Inc. (“Somaxon”) (NASDAQ: SOMX) following the approval of the transaction by stockholders of Somaxon at the special...
Benzinga  Dec 17  Comment 
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) today announced that its licensee Paladin Labs Inc. has received approval from Health Canada of Paladin's New Drug Submission (NDS) for Silenor^® (doxepin) for the treatment and symptomatic relief...
Benzinga  Dec 11  Comment 
Somaxon Pharmaceuticals (NASDAQ: SOMX) surged 93.20% to $2.84 at 9:45 am. Somaxon Pharma agreed to be acquired by Pernix Therapeutics Holdings (AMEX: PTX). TNS (NYSE: TNS) climbed 43.54% to $20.90. TNS agreed to be bought by an affiliate of...
StreetInsider.com  Dec 11  Comment 
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) 105% HIGHER; Pernix Therapeutics Holdings, Inc. (AMEX: PTX) will acquire Somaxon in a stock-for-stock transaction with a total equity value of $25 million TripAdvisor Inc. (NASDAQ: TRIP) INDICATED...
Benzinga  Dec 11  Comment 
Pernix Therapeutics (NYSE: PTX) and Somaxon Pharmaceuticals, Inc. (“Somaxon”) (NASDAQ: SOMX) today announced that they have entered into a definitive merger agreement for Pernix to acquire Somaxon in a stock-for-stock...
StreetInsider.com  Oct 31  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Somaxon+Pharmaceuticals%2C+Inc.+%28SOMX%29+Misses+Q3+EPS+by+30c/7832040.html for the full story.
StreetInsider.com  Oct 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Stock+Splits/Somaxon+%28SOMX%29+Announces+One-for-Eight+Stock+Split/7786461.html for the full story.
StreetInsider.com  Jul 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Somaxon+%28SOMX%29+Closes+9.4M+Direct+Offering%3B+Sees+Gross+Proceeds+of+%243M/7600914.html for the full story.
Globe Newswire  Jul 24  Comment 
SAN DIEGO, July 24, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, today announced that it has completed its previously announced registered direct offering of approximately 9.4 million




RELATED WIKI ARTICLES
 

Somaxon Pharmaceuticals (NASDAQ SOMX) is a Specialty Pharmaceutical company focused on the in-licensing, development and commercialization of proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area [1]

Company Overview

  • Somaxon Pharamaceuticals was founded in 2003 in Solana Beach, CA.
  • Its Initial Public Offering occured in December of 2005. The Fiscal Year ends on December 31st

Products

  1. Silenor




References

  1. [1]
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki